It also offers the advantage of avoiding a second operation in patients.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objectives To evaluate the safety and effectiveness of myomectomy during cesarean section Methods The data of fifty-four pregnants who underwent cesarean myomectomy and twenty-six pregnant with uterine leiomyoma who had cesarean section without myomectomy between the years of 2017 and 2020 in our tertiary clinic were examined retrospectively.
📊
Key Findings & Data:Results There was no significant difference in terms of maternal age, weeks of gestation, gravida, parity, use of additional uterotonics, type of leiomyoma, size of leiomyoma, cesarean indications, blood transfusion requirement, postoperative fever, preoperative hemoglobin (g/dl), change in hemoglobin (g/dl), preoperative hematocrit (%), change in hematocrit (%), length of hospital stay between the two groups (p ˃ 0.05).
💡
Conclusion & Impact:It also offers the advantage of avoiding a second operation in patients.
🔬Design:Research Article
📍Scope:2017 Verileri
⚙️Variables:Cesarean · Leiomyoma · Pregnancy
Abstract
Objectives To evaluate the safety and effectiveness of myomectomy during cesarean section Methods The data of fifty-four pregnants who underwent cesarean myomectomy and twenty-six pregnant with uterine leiomyoma who had cesarean section without myomectomy between the years of 2017 and 2020 in our tertiary clinic were examined retrospectively. Results There was no significant difference in terms of maternal age, weeks of gestation, gravida, parity, use of additional uterotonics, type of leiomyoma, size of leiomyoma, cesarean indications, blood transfusion requirement, postoperative fever, preoperative hemoglobin (g/dl), change in hemoglobin (g/dl), preoperative hematocrit (%), change in hematocrit (%), length of hospital stay between the two groups (p ˃ 0.05). While no significant difference was observed according to the location of the leiomyomas between the anterior, fundal and posterior location between the two groups, cervical leiomyomas were significantly higher in the CS group (p ˂ 0.05). Conclusion This study shows that cesarean myomectomy is a safe procedure in selected cases. It also offers the advantage of avoiding a second operation in patients.
GÜRSOY, A., ATASAYAN, K., TEKBAŞ, E. D., İLTER, E. (2021). The Dilemma of Cesarean Myomectomy: Is It Safe or Not. Journal of Experimental and Clinical Medicine, Cilt: 38 - Sayı: 4, 410–415. https://ajindex.com/articles/677813
Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol. 1990
94(4):435-438. doi:10.1093/ajcp/94.4.435 2. Lam SJ, Best S, Kumar S. The impact of fibroid characteristics on pregnancy outcome. Am J Obstet Gynecol. 2014
211(4):395.e1-395.e3955. doi:10.1016/j.ajog.2014.03.066 3. Milazzo GN, Catalano A, Badia V, Mallozzi M, Caserta D. Myoma and myomectomy: Poor evidence concern in pregnancy. J Obstet Gynaecol Res. 2017
43(12):1789-1804. doi:10.1111/jog.13437 4. Deveer M, Deveer R, Engin-Ustun Y, et al. Comparison of pregnancy outcomes in different localizations of uterine fibroids. Clin Exp Obstet Gynecol. 2012
39(4):516-518. 5. Chauhan AR. Cesarean myomectomy: necessity or opportunity? J Obstet Gynecol India. 2018
68(6):432–6. https://doi.org/10.1007/ s13224-018-1114-8. 6. Sarwar I, Habib S, Bibi A, Malik N, Parveen Z. Clinical audit of foetomaternal outcome in pregnancies with fibroid uterus. J Ayub Med Coll Abbottabad. 2012
24(1):79-82. 7. Warshak CR, Eskander R, Hull AD, et al. Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta. Obstet Gynecol. 2006
108(3 Pt 1):573-581. doi:10.1097/01.AOG.0000233155.62906.6d 8. Obara M, Hatakeyama Y, Shimizu Y. Vaginal Myomectomy for Semipedunculated Cervical Myoma during Pregnancy. AJP Rep. 2014
4(1):37-40. doi:10.1055/s-0034-1370352 9. Sparić R, Kadija S, Stefanović A, et al. Cesarean myomectomy in modern obstetrics: More light and fewer shadows. J Obstet Gynaecol Res. 2017
142(1-2):118-124. doi:10.2298/sarh1402118s 11. Sparić R, Malvasi A, Tinelli A. Analysis of clinical, biological and obstetric factors influencing the decision to perform cesarean myomectomy. Ginekol Pol. 2015
86(1):40-45. doi:10.17772/gp/1897 12. Sparić R, Malvasi A, Kadija S, Babović I, Nejković L, Tinelli A. Cesarean myomectomy trends and controversies: an appraisal. J Matern Fetal Neonatal Med. 2017
30(9):1114-1123. doi:10.1080/14767058.2016.1205024 13. Tinelli A, Mynbaev OA, Sparic R, et al. Angiogenesis and Vascularization of Uterine Leiomyoma: Clinical Value of Pseudocapsule Containing Peptides and Neurotransmitters. Curr Protein Pept Sci. 2017
18(2):129-139. doi:10.2174/1389203717666160322150338 14. Song D, Zhang W, Chames MC, Guo J. Myomectomy during cesarean delivery. Int J Gynaecol Obstet. 2013